Biohaven Pharmaceuticals

5 followers

‌

Biohaven is engaged in the identification and development of clinical stage compounds targeting the glutamatergic system.

Industries

Biotechnology

Headquarters

New Haven, United States

Employees

501-1,000

Links

Org chart

Vlad Coric

Chairman & CEO

Vlad Coric

Collapse

George Clark

VP, Chief Accounting Officer

Robert Croop

Chief Development Officer, Neurology

Bruce D. Car

Chief Scientific Officer

Tova Gardin

Chief Translational Officer

Matthew Buten

Chief Financial Officer

St John Donnie McGrath

Chief of Corporate Strategy & Business Development

Warren Volles

General Counsel & Chief Legal Officer

Cliff Bechtold

President & GM, Biohaven Ireland, Chief Compliance Officer

Michael Bozik

President, Ion Channel Research & Development

David Weaver

SVP, Neuroscience & Pharmacology

Kimberly Gentile

SVP, Clinical Operations

David Stock

VP, Biostatistics

Katy Mcgrath

Principal Scientist, In Vivo Science

Wes Kazmierski

Senior Director, Chemistry

Melissa Beiner

Director, R&D

Elyse Stock

Senior Scientific Advisor

Teams

+39

Leadership Team

42 members

+36

Clinical Operations Team

39 members

+26

Research and Development Team

29 members

Legal and Compliance Team

7 members

Offices

Similar companies

United Therapeutics

8 followers

Molecular Devices

2 followers

SOPHiA GENETICS

4 followers

Genentech

160 followers

Gilead Sciences

135 followers

Agilent Technologies

69 followers

Neuralink

62 followers

GRAIL

27 followers

BeiGene

24 followers

Cytokinetics

12 followers

Sarepta Therapeutics

9 followers

Explore companies